This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Alternative mechanisms of miR-34a regulation in cancer
Cell Death & Disease Open Access 12 October 2017
-
Characterization of human gastric carcinoma-related methylation of 9 miR CpG islands and repression of their expressions in vitro and in vivo
BMC Cancer Open Access 15 June 2012
-
Transcriptional activation of microRNA-34a by NF-kappa B in human esophageal cancer cells
BMC Molecular Biology Open Access 31 January 2012
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Chiorazzi N, Rai KR, Ferrarini M . Chronic lymphocytic leukemia. N Engl J Med 2005; 352: 804–815.
Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1910–1916.
Soussi T, Beroud C . Assessing TP53 status in human tumours to evaluate clinical outcome. Nat Rev Cancer 2001; 1: 233–240.
Bommer GT, Gerin I, Feng Y, Kaczorowski AJ, Kuick R, Love RE et al. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol 2007; 17: 1298–1307.
Welch C, Chen Y, Stallings RL . MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 2007; 26: 5017–5022.
van't Veer MB, Brooijmans AM, Langerak AW, Verhaaf B, Goudswaard CS, Graveland WJ et al. The predictive value of lipoprotein lipase for survival in chronic lymphocytic leukemia. Haematologica 2006; 91: 56–63.
Elstrodt F, Hollestelle A, Nagel JH, Gorin M, Wasielewski M, van den Ouweland A et al. BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants. Cancer Res 2006; 66: 41–45.
Boonstra JG, van Lom K, Langerak AW, Graveland WJ, Valk PJ, Kraan J et al. CD38 as a prognostic factor in B cell chronic lymphocytic leukaemia (B-CLL): comparison of three approaches to analyze its expression. Cytometry B Clin Cytom 2006; 70: 136–141.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dijkstra, M., van Lom, K., Tielemans, D. et al. 17p13/TP53 deletion in B-CLL patients is associated with microRNA-34a downregulation. Leukemia 23, 625–627 (2009). https://doi.org/10.1038/leu.2008.264
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2008.264
This article is cited by
-
The comprehensive landscape of miR-34a in cancer research
Cancer and Metastasis Reviews (2021)
-
Expression levels of miR-34-family microRNAs are associated with TP53 mutation status in head and neck squamous cell carcinoma
European Archives of Oto-Rhino-Laryngology (2019)
-
Alternative mechanisms of miR-34a regulation in cancer
Cell Death & Disease (2017)
-
Mir-34: A New Weapon Against Cancer?
Molecular Therapy - Nucleic Acids (2014)
-
The tumor suppressor axis p53/miR-34a regulates Axl expression in B-cell chronic lymphocytic leukemia: implications for therapy in p53-defective CLL patients
Leukemia (2014)